Applied StemCell Inc.

Applied StemCell is a pioneering clinic specializing in advanced genome engineering technologies, particularly in the realm of induced pluripotent stem cells (iPSCs). The clinic offers a comprehensive range of bespoke services designed to accelerate the development of cell therapies, including iPSC generation, gene editing, and differentiation into targeted cell types. Utilizing cutting-edge platforms such as the TARGATT™ large cargo knock-in technology and S-SELeCT™ technology, Applied StemCell provides clients with tailored solutions that meet specific therapeutic needs. Their expertise in CRISPR/Cas9 gene editing and Mad7 variants further enhances their capability to create fit-for-purpose cell lines, ensuring that each project is executed with precision and efficiency. In addition to its advanced gene editing services, the clinic is committed to maintaining high standards of quality and regulatory compliance through its cGMP (current Good Manufacturing Practice) cell banking and manufacturing processes. This ensures that clients receive not only innovative solutions but also the reliability and safety necessary for therapeutic applications. With a strong focus on hypoimmunogenicity in their iPSC lines via proprietary techniques, Applied StemCell stands out in the industry by offering products that are ready for additional gene knock-ins and feature consistent transgene expression, paving the way for the development of groundbreaking allogeneic therapies. The clinic's dedication to advancing the field of regenerative medicine makes it a vital partner for researchers and companies striving to bring transformative treatments to market.